Woodline Partners’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.26M | Hold |
400,278
| – | – | 0.03% | 547 |
|
|
2025
Q1 | $5.76M | Sell |
400,278
-145,367
| -27% | -$2.09M | 0.04% | 469 |
|
|
2024
Q4 | $9.14M | Buy |
545,645
+29,266
| +6% | +$490K | 0.06% | 363 |
|
|
2024
Q3 | $8.26M | Buy |
516,379
+392,918
| +318% | +$6.28M | 0.07% | 328 |
|
|
2024
Q2 | $1.11M | Buy |
+123,461
| New | +$1.11M | 0.01% | 450 |
|
|
2024
Q1 | – | Sell |
-140,856
| Closed | -$1.12M | – | 551 |
|
|
2023
Q4 | $1.12M | Sell |
140,856
-69,348
| -33% | -$552K | 0.01% | 397 |
|
|
2023
Q3 | $1.36M | Sell |
210,204
-477,559
| -69% | -$3.09M | 0.02% | 424 |
|
|
2023
Q2 | $4.26M | Sell |
687,763
-48,230
| -7% | -$299K | 0.05% | 313 |
|
|
2023
Q1 | $2.83M | Buy |
735,993
+516,573
| +235% | +$1.99M | 0.04% | 376 |
|
|
2022
Q4 | $680K | Buy |
219,420
+40,852
| +23% | +$127K | 0.01% | 572 |
|
|
2022
Q3 | $718K | Sell |
178,568
-1,136,084
| -86% | -$4.57M | 0.01% | 559 |
|
|
2022
Q2 | $6.4M | Buy |
1,314,652
+432,019
| +49% | +$2.1M | 0.1% | 222 |
|
|
2022
Q1 | $7.92M | Buy |
882,633
+81,497
| +10% | +$731K | 0.13% | 194 |
|
|
2021
Q4 | $9.02M | Sell |
801,136
-81,677
| -9% | -$920K | 0.13% | 209 |
|
|
2021
Q3 | $14.7M | Buy |
882,813
+60,295
| +7% | +$1.01M | 0.24% | 113 |
|
|
2021
Q2 | $18.3M | Buy |
+822,518
| New | +$18.3M | 0.34% | 77 |
|